Personalis reported record revenues of $19.2 million for the first quarter of 2020, a 36% increase compared to the first quarter of 2019. Revenue growth was driven by increased volume for testing and analytical services provided to the VA MVP. The company reported a net loss of $9.1 million, or $0.29 per share.
Reported record revenues of $19.2 million, a 36% increase year-over-year.
VA MVP accounted for 77% of revenues, totaling $14.8 million.
26 customers have placed orders for NeXT as of March 31, 2020.
Received a new order outside of oncology to deliver neoantigen prediction.
Due to uncertainty surrounding the COVID-19 pandemic, Personalis will not provide an outlook for fiscal 2020 at this time, and will plan to give an update during its second quarter earnings announcement and press release, to the extent practicable, based on available information at that time.
Analyze how earnings announcements historically affect stock price performance